title: Detection of integrons among multi-drug resistant (MDR) Escherichia coli strains isolated from clinical specimens in northern west of Iran.
abstract: Transference of resistance determinants by integrons is one of the important factors that can contribute to the increase in multi-resistant bacteria. We determined the prevalence and class of integrons among multi-drug resistant (MDR) Escherichia coli strains isolated from clinical specimens in Tabriz teaching hospitals. Firstly, susceptibility of 140 isolates to 13 antibiotics was determined using the disc diffusion method. Then, prevalence and class of integrons was detected in MDR strains by PCR-RFLP. One hundred five (75%) of total 140 isolates were uropathogenic Escherichia coli (UPEC). Other pathotypes included were: diarrheagenic Escherichia coli (13; 9.3%), sepsis-associated E. coli (5; 3.6%) and newborn meningitis-associated E. coli (2; 1.4%). Antibiotic resistance patterns were as follows: amoxicillin 99.3%, gentamicin 33.6%, tetracycline 72.8%, ceftazidime 46.4%, co-trimoxazole 75%, imipenem 1.4%, ciprofloxacin 47.6%, norfloxacin 50.7%, cephalothin 77.8%, amikacin 12.1%, nitrofurantoin 12.9%, chloramphenicol 20.7% and nalidixic acid 60.7%. One hundred eighteen (84.2%) of tested isolates were multi-drug resistant. Prevalence of integrons was confirmed in 27.1% of MDR isolates. intI1 and intI2 were detected respectively in 22.05% and 5.08% of MDR strains. No intI3 was detected. Resistance to gentamicin, amikacin and chloramphenicol was significantly associated with the presence of integrons. These results showed high resistance of E. coli to routine antibiotics, however, in consideration of low prevalence of integrons among these strains, we can conclude that antibiotic resistance genes in these strains presumably carried on elements other than integrons.
authors.affiliation: Research Center of Infectious Diseases and Tropical Medicine, Department of Medical Microbiology, Faculty of Medicine, Tabriz University of Medical Sciences , Tabriz , Iran.
authors.forename: Mohammad Ahangarzadeh
authors.initials: MA
authors.lastname: Rezaee
authors.forename: Vajihe
authors.initials: V
authors.lastname: Sheikhalizadeh
authors.forename: Alka
authors.initials: A
authors.lastname: Hasani
keywords: Escherichia coli; Integron; Multi-drug resistance
references.citation: Clin Microbiol Infect. 2004 Apr;10(4):272-88
references.pmid: 15059115
references.citation: BMC Genomics. 2010 Oct 21;11:591
references.pmid: 20964857
references.citation: J Clin Microbiol. 2007 Oct;45(10):3352-9
references.pmid: 17715376
references.citation: Antimicrob Agents Chemother. 1999 Mar;43(3):686-9
references.pmid: 10049290
references.citation: Antimicrob Agents Chemother. 2001 Sep;45(9):2658-61
references.pmid: 11502548
references.citation: Jpn J Infect Dis. 2008 Jan;61(1):85-8
references.pmid: 18219144
references.citation: Antimicrob Agents Chemother. 2004 Oct;48(10):3996-4001
references.pmid: 15388464
references.citation: J Infect Dis. 2003 Jan 15;187(2):251-9
references.pmid: 12552449
references.citation: APMIS. 2004 Mar;112(3):159-64
references.pmid: 15153157
references.citation: Clin Microbiol Infect. 2005 Nov;11(11):898-902
references.pmid: 16216105
references.citation: Clin Infect Dis. 2004 Jan 1;38(1):78-85
references.pmid: 14679451
references.citation: Clin Microbiol Infect. 2005 Mar;11(3):185-92
references.pmid: 15715715
references.citation: J Clin Microbiol. 2003 Dec;41(12):5429-33
references.pmid: 14662921
references.citation: Vet Res. 2001 May-Aug;32(3-4):243-59
references.pmid: 11432416
references.citation: Emerg Infect Dis. 2006 Jun;12(6):1011-4
references.pmid: 16707065
references.citation: Emerg Infect Dis. 2005 Apr;11(4):546-53
references.pmid: 15829192
references.citation: J Clin Microbiol. 2002 Aug;40(8):3038-40
references.pmid: 12149373
references.citation: Clin Microbiol Infect. 2004 Feb;10(2):156-62
references.pmid: 14759241